|
?:reviewBody
|
-
On 16 January 2016, Britain's Sky News was one of many outlets reporting on significant adverse events during a French drug trial: On 15 January 2016, Biotrial tweeted a brief statement about the event. However, the research lab made no mention of cannabis: On 15 January 2016 the English-language French news source TheLocal published an article titled Botched drugs trial leaves volunteer brain-dead in France. That local reporting included comments from French health authorities who denied the drug in question was cannabis-based, noting that the rumor began in France. Moreover, the outlet stated that the patient reported brain dead may actually be in a coma, with a chance for recovery: Both the BBC and New York Times covered the event; the former included Touraine's remarks, and the latter described the adverse event as an accident: So while a January 2016 adverse event occurred during a drug trial in France, that event remains under investigation. Moreover, French health authorities have confirmed that the medication in question was not cannabis-based.
(en)
|
![[This page as RDF]](http://data.gesis.org/claimskg/static/rdf-icon.gif){kind=icon}